Clin2
NCT06891300Possibly a fitRecruiting

Ketamine for Suicidal Thoughts in Depression

Suicidal IdeationMajor Depressive Disorder (MDD)

Treatments studied

Part of Mental health clinical trials.

This study tests if ketamine can help reduce suicidal thoughts in people with major depression. You'll receive ketamine treatment and be monitored closely.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
36 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must be between 18 and 65 years old.
  • You must have major depression with active suicidal thoughts.
  • You must be able to speak and understand English.
  • You must have a regular doctor to continue your care after the study.
  • You must be willing to keep your current medications stable during the trial.
  • You cannot have certain medical conditions like high blood pressure, diabetes, or a high BMI.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06366334Recruiting
Ketamine for Teens with Suicidal Thoughts in the ER

This study tests whether a single dose of ketamine, given through an IV, can quickly reduce suicidal thoughts in teenagers who come to the emergency department. It aims to find a faster way to help teens in crisis.

Ottawa, Ontario
NCT07139106Not yet recruiting· Phase 4
Ketamine and brain opioid receptors for suicidal thoughts

This study tests how ketamine affects brain chemicals linked to suicidal thoughts in people with depression. You will receive ketamine and have brain scans (PET and MRI) to see if it changes activity in opioid receptors.

New York, New York
NCT06085937Recruiting· Phase 1
Ketamine for suicidal patients in the ER

This trial tests if a single dose of ketamine can quickly reduce suicidal thoughts in people who come to the emergency department. If you are having active suicidal thoughts and need inpatient care, you may be able to join.

Kansas City, Kansas
NCT07569198Recruiting· Phase 2
Ketamine plus therapy for depression with suicidal thoughts

This study tests whether ketamine (a medication) combined with a specific type of therapy called DBT can help people with treatment-resistant depression and borderline personality disorder who are having thoughts of suicide. You would receive ketamine infusions alongside structured therapy sessions over 6 months.

Toronto, Ontario
NCT07602153Not yet recruiting
Study of medications for depression with suicidal thoughts

This research study tests different medication approaches for people with major depression who are having thoughts of suicide. The goal is to understand which treatments work best and why, so doctors can help patients more effectively.

NCT06788249Recruiting· Early Phase 1
Ketamine for treatment-resistant depression brain study

This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.

Philadelphia, Pennsylvania

Hear when a new Suicidal Ideation trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.